Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation
Journal of Atherosclerosis and Thrombosis · 01.08.2026 · 33 (8) · 1015-1024
DOI: 10.5551/jat.66057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.08.2026. Verfasst von Ryuki Kitamoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Otsuka Pharmaceutical Co., Ltd. Hauptthemen laut MEDLINE: ATP Citrate (pro-S)-Lyase, Fatty Acids, Dicarboxylic Acids, Lipid Metabolism. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs, Otsuka Pharmaceutical Co., Ltd.
- Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba.
Zitieren
APA
Kitamoto, R., Morikawa-Isogai, Y., & Shimano, H. (2026). Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation. Journal of Atherosclerosis and Thrombosis, 33(8), 1015-1024. https://doi.org/10.5551/jat.66057
Vancouver
Kitamoto R, Morikawa-Isogai Y, Shimano H. Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation. Journal of Atherosclerosis and Thrombosis. 2026;33(8):1015-1024. doi:10.5551/jat.66057
BibTeX
@article{Kitamoto2026,
author = {Kitamoto, Ryuki and Morikawa-Isogai, Yuki and Shimano, Hitoshi},
title = {Perspectives on Bempedoic Acid, ATP-citrate lyase inhibitor: Targeting Lipid Metabolism and Inflammation},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
volume = {33},
number = {8},
pages = {1015--1024},
doi = {10.5551/jat.66057}
}
EUVIMED